Loss of Arrowhead Pharmaceuticals under GAAP for the fiscal year 2020 amounted to $84.553 million, against a profit of $67.975 million in the previous year. Revenue decreased by 47.9% to $87.992 million against $168.796 million a year earlier.
Loss of Arrowhead Pharmaceuticals under GAAP for the fiscal year 2020 amounted to $84.553 million, against a profit of $67.975 million in the previous year. Revenue decreased by 47.9% to $87.992 million against $168.796 million a year earlier. 
ir.arrowheadpharma.com
English (US) 